Apnimed

Last updated: June 14, 2024

Larry Miller, CEO
Larry Miller, CEO
USA | Funding: $207.8M (+)

Website: https://apnimed.com/

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.